Literature DB >> 27803100

How the TRAMP Model Revolutionized the Study of Prostate Cancer Progression.

Irwin H Gelman1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27803100     DOI： 10.1158/0008-5472.CAN-16-2636

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  10 in total

1.  Castration Determines the Efficacy of ETAR Blockade in a Mouse Model of Prostate Cancer Bone Metastasis.

Authors:  Henry H Moon; Katrina L Clines; Mark A Cooks; Charlotte A Cialek; Marian A Esvelt; Gregory A Clines
Journal:  Endocrinology       Date:  2019-08-01       Impact factor: 4.736

2.  Zinc as an Imaging Biomarker of Prostate Cancer.

Authors:  Su-Tang Lo; André F Martins; Veronica Clavijo Jordan; A Dean Sherry
Journal:  Isr J Chem       Date:  2017-07-31       Impact factor: 3.333

Review 3.  Development of Zinc-Specific iCEST MRI as an Imaging Biomarker for Prostate Cancer.

Authors:  Yue Yuan; Zhiliang Wei; Chengyan Chu; Jia Zhang; Xiaolei Song; Piotr Walczak; Jeff W M Bulte
Journal:  Angew Chem Int Ed Engl       Date:  2019-09-17       Impact factor: 15.336

Review 4.  Proteomic discovery of non-invasive biomarkers of localized prostate cancer using mass spectrometry.

Authors:  Amanda Khoo; Lydia Y Liu; Julius O Nyalwidhe; O John Semmes; Danny Vesprini; Michelle R Downes; Paul C Boutros; Stanley K Liu; Thomas Kislinger
Journal:  Nat Rev Urol       Date:  2021-08-27       Impact factor: 14.432

Review 5.  Prostate Luminal Progenitor Cells in Development and Cancer.

Authors:  Dingxiao Zhang; Shuhong Zhao; Xinyun Li; Jason S Kirk; Dean G Tang
Journal:  Trends Cancer       Date:  2018-10-01

6.  P21 and P27 promote tumorigenesis and progression via cell cycle acceleration in seminal vesicles of TRAMP mice.

Authors:  Tonghui Li; Fangfang Wang; Yanmei Dang; Jiajie Dong; Yu Zhang; Chi Zhang; Ping Liu; Yanhong Gao; Xiaojun Wang; Sijun Yang; Shan Lu
Journal:  Int J Biol Sci       Date:  2019-08-19       Impact factor: 6.580

Review 7.  Past, Current, and Future of Immunotherapies for Prostate Cancer.

Authors:  Adeline N Boettcher; Ahmed Usman; Alicia Morgans; David J VanderWeele; Jeffrey Sosman; Jennifer D Wu
Journal:  Front Oncol       Date:  2019-09-11       Impact factor: 6.244

8.  Differential expression of αVβ3 and αVβ6 integrins in prostate cancer progression.

Authors:  Fabio Quaglia; Shiv Ram Krishn; Yanqing Wang; David W Goodrich; Peter McCue; Andrew V Kossenkov; Amy C Mandigo; Karen E Knudsen; Paul H Weinreb; Eva Corey; William K Kelly; Lucia R Languino
Journal:  PLoS One       Date:  2021-01-22       Impact factor: 3.240

9.  Differential expressions of integrin-linked kinase, β-parvin and cofilin 1 in high-fat diet induced prostate cancer progression in a transgenic mouse model.

Authors:  Meng-Bo Hu; Ji-Meng Hu; Li-Ren Jiang; Tian Yang; Wen-Hui Zhu; Yun Hu; Xiao-Bo Wu; Hao-Wen Jiang; Qiang Ding
Journal:  Oncol Lett       Date:  2018-08-07       Impact factor: 2.967

10.  Galectin-3 in Prostate Cancer Stem-Like Cells Is Immunosuppressive and Drives Early Metastasis.

Authors:  Sara Caputo; Matteo Grioni; Chiara S Brambillasca; Antonella Monno; Arianna Brevi; Massimo Freschi; Ignazio S Piras; Angela R Elia; Valentina Pieri; Tania Baccega; Angelo Lombardo; Rossella Galli; Alberto Briganti; Claudio Doglioni; Elena Jachetti; Matteo Bellone
Journal:  Front Immunol       Date:  2020-09-10       Impact factor: 7.561
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.